CT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients
NCT03976310
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Interventions
DRUG:
48 weeks of Benralizumab
OTHER:
Computed tomography
Sponsor
University Hospital, Montpellier
Collaborators
[object Object]